Latest Regulatory News

Page 188 of 746
Astron Limited has sold a significant portion of its Energy Fuels shares, generating A$15.2 million to bolster financial flexibility as it advances the pivotal Donald Project towards production.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.
Ada Torres
Ada Torres
25 Nov 2025
Bougainville Copper Limited reveals complications in its Panguna Project partnership efforts following the Autonomous Bougainville Government's unexpected MOU with Lloyds Metals and Energy Limited.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Zeotech Limited’s AusPozz™ has been independently validated by BG&E as a high-performance, low-carbon supplementary cementitious material, showing remarkable strength gains and durability benefits in concrete applications.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Iress Limited has responded to an ASX price query, denying any undisclosed information behind recent share price movements while acknowledging ongoing strategic discussions.
Sophie Babbage
Sophie Babbage
25 Nov 2025
Bendigo and Adelaide Bank has revealed systemic deficiencies in its anti-money laundering and counter-terrorism financing controls following a Deloitte investigation, committing to comprehensive remediation efforts.
Claire Turing
Claire Turing
25 Nov 2025
IPD Group’s 2025 AGM reveals robust FY25 financial results driven by data centre and electrification sectors, alongside operational efficiencies and sustainability strides. The company signals continued momentum into FY26 with positive earnings guidance.
Victor Sage
Victor Sage
25 Nov 2025
Acrux Ltd reported a remarkable surge in licensing revenue from its topical generics portfolio alongside a strategic pivot towards innovative drug delivery R&D at its 2025 Annual General Meeting.
Ada Torres
Ada Torres
25 Nov 2025
Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.
Ada Torres
Ada Torres
25 Nov 2025
Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.
Ada Torres
Ada Torres
25 Nov 2025
Catalina Resources is set to launch a significant Phase 1 drilling campaign across its Evanston and Yerilgee gold projects starting December 1, 2025, aiming to deepen understanding of promising mineralised zones.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Corazon Mining has formalised a key land access agreement with the Marputu Aboriginal Corporation, securing tenure and advancing exploration plans at its Two Pools Gold Project in Western Australia.
Maxwell Dee
Maxwell Dee
25 Nov 2025